Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-08-12

FDA Approved: BRINSUPRI — Original Application (Insmed Incorporated)

View source ↗

Summary

The FDA approved BRINSUPRI (BRENSOCATIB) from Insmed as a new therapy for adults with bronchiectasis to reduce exacerbations. This original NDA approval represe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRINSUPRI (BRENSOCATIB)

Snippet

ORIG AP for BRINSUPRI (BRENSOCATIB)